Suppr超能文献

[Equine granulocytic anaplasmosis (EGA): Case description and overview of the epidemiological situation with focus on Germany].

作者信息

Axt Carla Wiebke, Springer Andrea, Besse Arno, Naucke Torsten J, Müller Elisabeth, Strube Christina, Schäfer Ingo

机构信息

Laboklin GmbH and Co. KG, Bad Kissingen.

Institut für Parasitologie, Zentrum für Infektionsmedizin, Stiftung Tierärztliche Hochschule Hannover, Hannover.

出版信息

Tierarztl Prax Ausg G Grosstiere Nutztiere. 2024 Dec;52(6):352-360. doi: 10.1055/a-2418-6540. Epub 2024 Dec 4.

Abstract

Equine granulocytic anaplasmosis (EGA) is a tick-borne disease caused by (.) . In Central, Northern, Western, and Eastern Europe, ticks of the (.) / complex, in Germany mainly , are considered as vectors. ticks show peaks of activity during the spring and summer months, particularly April to July. Changing climatic conditions, however, have meanwhile led to a year-round risk of tick exposure and thus infections with . The presented case report underlines the seasonal peak phase of the infection risk in that the presentation of the horse to the veterinarian occurred in June. Additionally, clinical signs - including fever - are mostly unspecific and thrombocytopenia represents the most significant hematological abnormality. Direct and indirect detection methods are available for the diagnosis of an infection or contact with the pathogen. A positive PCR confirms an acute infection, as in the presented case, while positive antibody levels indicate contact with the pathogen in the (recent) past. Additionally, inclusion bodies, so called morulae, may be detected rapidly and inexpensively in smears derived from the peripheral blood and are predominantly found in neutrophilic granulocytes, less frequently in eosinophilic granulocytes. However, microscopy has a lower sensitivity compared to PCR-testing. In the presented case, morulae could not be detected in EDTA blood despite positive PCR. Antibiotics with intracellular activity, such as oxytetracycline and/or doxycycline are the treatment of choice and, as in the described case, often result in rapid clinical improvement in horses suffering from EGA. The elimination of the pathogen should be confirmed by PCR-testing 5-8 days after the completion of the antibiotic therapy. Whether and how long antibodies against could possibly be protective against reinfection remains unknown. In humans, is classified as an emerging pathogen of increasing clinical importance in the northern hemisphere.

摘要

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验